183 related articles for article (PubMed ID: 22277026)
1. Photodynamic therapy in a teenage girl with xeroderma pigmentosum type C.
Larson DM; Cunningham BB
Pediatr Dermatol; 2012; 29(3):373-4. PubMed ID: 22277026
[TBL] [Abstract][Full Text] [Related]
2. Daylight photodynamic therapy is an option for the treatment of actinic keratosis in patients with xeroderma pigmentosum in Africa.
Fernández-Guarino M; Mavura D; Fernández-González P; Chapa P; Ravazzano C; Jaén L; Rios L; Jaén P; Grossman H
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101631. PubMed ID: 31904551
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of non-melanoma skin cancer in three patients with Xeroderma Pigmentosum by modified ALA-PDT.
Zheng J; Liu W; Zhou Z; Cao Z; Zhao Z; Wang X; Li M; Zhang G
Photodiagnosis Photodyn Ther; 2023 Sep; 43():103694. PubMed ID: 37422200
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy in the treatment of xeroderma pigmentosum: A case report.
Cai H; Yang QQ; Ma C; Zou DX; Wang YX; Sun P; Ju AQ; Fang F; Gong S; Liu W
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101761. PubMed ID: 32283311
[TBL] [Abstract][Full Text] [Related]
5. Current treatments of actinic keratosis.
Gold MH; Nestor MS
J Drugs Dermatol; 2006 Feb; 5(2 Suppl):17-25. PubMed ID: 16485877
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
7. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
[TBL] [Abstract][Full Text] [Related]
8. An economic evaluation of topical treatments for actinic keratosis.
Muston D; Downs A; Rives V
J Dermatolog Treat; 2009; 20(5):266-75. PubMed ID: 19421918
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for actinic keratosis followed by 5-fluorouracil reaction.
Marcus L
Dermatol Surg; 2003 Oct; 29(10):1061-4; discussion 1064-5. PubMed ID: 12974706
[TBL] [Abstract][Full Text] [Related]
10. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
Morton CA
Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
[TBL] [Abstract][Full Text] [Related]
11. Daylight photodynamic therapy: the Southern California experience.
Lane KL; Hovenic W; Ball K; Zachary CB
Lasers Surg Med; 2015 Feb; 47(2):168-72. PubMed ID: 25663047
[TBL] [Abstract][Full Text] [Related]
12. Aminolevulinic acid photodynamic therapy for actinic keratoses/actinic cheilitis/acne: vascular lasers.
Alexiades-Armenakas M
Dermatol Clin; 2007 Jan; 25(1):25-33. PubMed ID: 17126739
[TBL] [Abstract][Full Text] [Related]
13. Prospective, case-based assessment of sequential therapy with topical Fluorouracil cream 0.5% and ALA-PDT for the treatment of actinic keratosis.
Martin G
J Drugs Dermatol; 2011 Apr; 10(4):372-8. PubMed ID: 21455547
[TBL] [Abstract][Full Text] [Related]
14. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
15. Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis.
Jeffes EW
J Dermatolog Treat; 2002; 13 Suppl 1():S19-23. PubMed ID: 12060513
[TBL] [Abstract][Full Text] [Related]
16. The use of photodynamic therapy in dermatology: results of a consensus conference.
Nestor MS; Gold MH; Kauvar AN; Taub AF; Geronemus RG; Ritvo EC; Goldman MP; Gilbert DJ; Richey DF; Alster TS; Anderson RR; Bank DE; Carruthers A; Carruthers J; Goldberg DJ; Hanke CW; Lowe NJ; Pariser DM; Rigel DS; Robins P; Spencer JM; Zelickson BD
J Drugs Dermatol; 2006 Feb; 5(2):140-54. PubMed ID: 16485882
[TBL] [Abstract][Full Text] [Related]
17. Aminolevulinic acid photodynamic therapy: medical evidence for its expanded use.
Gold MH
Expert Rev Med Devices; 2006 May; 3(3):357-71. PubMed ID: 16681457
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based evaluation of photodynamic therapy of actinic keratoses.
Epstein E
J Am Acad Dermatol; 2003 Feb; 48(2):304; author reply 304-6. PubMed ID: 12582414
[No Abstract] [Full Text] [Related]
19. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy for actinic keratoses.
Kalisiak MS; Rao J
Dermatol Clin; 2007 Jan; 25(1):15-23. PubMed ID: 17126738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
